Patents by Inventor Pierrick Uzureau

Pierrick Uzureau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Analysis Method of Blood Platelets Aggregate
    Publication number: 20180114315
    Abstract: Quantitative analysis of blood platelets or aggregates in 3D by Digital Holographic Microscopy. The present invention is related to a method for the quantitative analysis of blood platelets or blood platelet aggregates comprising the steps of: a) providing a sample comprising platelets aggregates; b) obtain a 3D representation of the platelets aggregates by the use of DHM or DDHM; c) extract quantitative information about the platelets aggregates from said 3D representation.
    Type: Application
    Filed: April 25, 2016
    Publication date: April 26, 2018
    Inventors: Frank Dubois, Catherine Yourassowsky, Pierrick Uzureau, Daniel Ribeiro De Souza, Karim Zouaoui Boudjeltia
  • Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3? UTR of SUB2 and the SUB2 serine protease
    Patent number: 8329883
    Abstract: Methods for regulating the serine protease of Plasmodium. Recombinant DNA constructs which express the Plasmodium serine protease, especially those comprising a sub2 3?UTR and coding segment which express a SUB2 a serine protease. Recombinant Plasmodium containing such constructs and exhibiting increased virulence. Methods for detecting virulent Plasmodium strains by detecting the presence or amount of sub2 3?UTR sequences, sub2 mRNA or cDNA, SUB2 polypeptide expression, or other Plasmodium proteins, such as AMA1 or MSP1, which have been post-translationally modified by SUB2.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: December 11, 2012
    Assignee: Institut Pasteur
    Inventors: Jean-Christophe Barale, Pierrick Uzureau, Catherine Braun-Breton
  • Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3?UTR of SUB2 and the SUB2 serine protease
    Patent number: 8012706
    Abstract: Methods for regulating the serine protease of Plasmodium. Recombinant DNA constructs which express the Plasmodium serine protease, especially those comprising a sub2 3?UTR and coding segment which express a SUB2 a serine protease. Recombinant Plasmodium containing such constructs and exhibiting increased virulence. Methods for detecting virulent Plasmodium strains by detecting the presence or amount of sub2 3?UTR sequences, sub2 mRNA or cDNA, SUB2 polypeptide expression, or other Plasmodium proteins, such as AMA1 or MSP1, which have been post-translationally modified by SUB2.
    Type: Grant
    Filed: May 3, 2005
    Date of Patent: September 6, 2011
    Assignee: Institut Pasteur
    Inventors: Jean-Christophe Barale, Pierrick Uzureau, Catherine Braun-Breton
  • METHODS FOR DETECTING VIRULENT PLASMODIUM, FOR EVALUATING PLASMODIUM VIRULENCE, AND FOR SCREENING NEW DRUGS EMPLOYING THE 3'UTR OF PLASMODIUM SUB2 AND THE PLASMODIUM SUB2 SERINE PROTEASE
    Publication number: 20110039262
    Abstract: Methods for regulating the serine protease of Plasmodium. Recombinant DNA constructs which express the Plasmodium serine protease, especially those comprising a sub2 3?UTR and coding segment which express a SUB2 a serine protease. Recombinant Plasmodium containing such constructs and exhibiting increased virulence. Methods for detecting virulent Plasmodium strains by detecting the presence or amount of sub2 3?UTR sequences, sub2 mRNA or cDNA, SUB2 polypeptide expression, or other Plasmodium proteins, such as AMA1 or MSP1, which have been post-translationally modified by SUB2.
    Type: Application
    Filed: July 21, 2010
    Publication date: February 17, 2011
    Applicant: INSTITUT PASTEUR
    Inventors: Jean-Christophe BARALE, Pierrick Uzureau, Catherine Braun-Breton
  • Methods for detecting virulent Plasmodium, for evaluating Plasmodium virulence, and for screening new drugs employing the 3'UTR of Plasmodium SUB2 and the Plasmodium SUB2 serine protease
    Publication number: 20070014817
    Abstract: Methods for regulating the serine protease of Plasmodium. Recombinant DNA constructs which express the Plasmodium serine protease, especially those comprising a sub2 3?UTR and coding segment which express a SUB2 a serine protease. Recombinant Plasmodium containing such constructs and exhibiting increased virulence. Methods for detecting virulent Plasmodium strains by detecting the presence or amount of sub2 3?UTR sequences, sub2 mRNA or cDNA, SUB2 polypeptide expression, or other Plasmodium proteins, such as AMA1 or MSP1, which have been post-translationally modified by SUB2.
    Type: Application
    Filed: May 3, 2005
    Publication date: January 18, 2007
    Applicant: INSTITUT PASTEUR
    Inventors: Jean-Christophe Barale, Pierrick Uzureau, Catherine Braun-Breton